Loading web-font TeX/Main/Regular
Preclinical Validation of Electrodes for Single Anodal Transcranial Direct Current Stimulation on Rat Model With Chronic Stress-Induced Depression | IEEE Journals & Magazine | IEEE Xplore

Preclinical Validation of Electrodes for Single Anodal Transcranial Direct Current Stimulation on Rat Model With Chronic Stress-Induced Depression


Abstract:

Transcranial direct current stimulation (tDCS) is an effective and safe noninvasive brain stimulation (NIBS) procedure to modulate neuronal excitability. The present prec...Show More

Abstract:

Transcranial direct current stimulation (tDCS) is an effective and safe noninvasive brain stimulation (NIBS) procedure to modulate neuronal excitability. The present preclinical study was carried out to validate the impact of the innovative high definition (HD) fabricated spiking Au/AgCl electrodes via a noninvasive tDCS procedure on a rat model with depression-like behavior. In this study, a chronic stress-induced depression-like behavior rat model was developed over a period of 14 days. Furthermore, the aftereffects of NIBS procedures were investigated by providing a tDCS dose ( {2.00} \text {mA} \times {5.00} \text {min} ) by placing the electrodes on the interested region of the rat brain. This study was performed in healthy rats, control rats with depression-like behavior, and tDCS treated rats, which were used to examine the differential aftereffects of tDCS dose. After single tDCS dose, a significant increase in average band power of electroencephalogram (EEG) has been observed ( \text {F}{(}{2},{15}{)} = {8.376}; {P} = {0.0036} ) alongside a significant increase in the glutamate level of hippocampus (HPC; \text {F}{(}{2},\!{15}{)} = {8.919}; {P} = {0.0028} ), a significant reduction in immobility time ( \text {F}{(}{2},{15}{)} = {7.552}; {P} = {0.0054} ), and a significant increase in the percentage sucrose intake has been observed ( \text {F}{(}{2}, {15}{)} = {5.941}; {P} = {0.0126} ). In addition, immunohistochemistry (IHC) showed a significant increase in the Iba1 protein expression in microglia cell in the both cortex and HPC region ( {P} < {0.05} ). Hence, the fabricated electrodes can deliver a tDCS dose that can penetrate up to the cortex and HPC regions from the surface of brain noninvasively within tolerable and safety limits.
Published in: IEEE Sensors Journal ( Volume: 23, Issue: 11, 01 June 2023)
Page(s): 12133 - 12145
Date of Publication: 20 April 2023

ISSN Information:

Funding Agency:

Author image of Gaurav Sharma
Cognitive Brain Dynamics Laboratory, National Brain Research Centre (NBRC), Manesar, Haryana, India
Gaurav Sharma was born in Bharmout, Una, Himachal Pradesh, India, in August 1990. He received the M.Tech. degree in electronics and communication from Punjabi University, Patiala, India, in 2015, and the Ph.D. degree from the Indian Institute of Technology Mandi, Mandi, India, in 2021.
He is currently working as a Project Scientist-I and a Postdoctoral Fellow with the Cognitive Brain Dynamics Laboratory, National Brain Res...Show More
Gaurav Sharma was born in Bharmout, Una, Himachal Pradesh, India, in August 1990. He received the M.Tech. degree in electronics and communication from Punjabi University, Patiala, India, in 2015, and the Ph.D. degree from the Indian Institute of Technology Mandi, Mandi, India, in 2021.
He is currently working as a Project Scientist-I and a Postdoctoral Fellow with the Cognitive Brain Dynamics Laboratory, National Brain Res...View more
Author image of Shubham Nilkanth Rahmatkar
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Shubham Nilkanth Rahmatkar received the master’s degree in pharmacology from the S.K.B. College of Pharmacy, Maharashtra, India, in 2018. He is pursuing the Ph.D. degree in pharmacology with the Academy of Scientific and Innovative Research (AcSIR), Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India.
In his master’s, he explored the role of hippocampal a...Show More
Shubham Nilkanth Rahmatkar received the master’s degree in pharmacology from the S.K.B. College of Pharmacy, Maharashtra, India, in 2018. He is pursuing the Ph.D. degree in pharmacology with the Academy of Scientific and Innovative Research (AcSIR), Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India.
In his master’s, he explored the role of hippocampal a...View more
Author image of Anil Kumar Rana
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Anil Kumar Rana received the master’s degree in molecular and human genetics from the Centre for Genomics, Jiwaji University, Gwalior, India, in 2014. He is pursuing the Ph.D. degree in neuroscience with the Academy of Scientific and Innovative Research (AcSIR), Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India, on understanding the role of Gsk-3 in ne...Show More
Anil Kumar Rana received the master’s degree in molecular and human genetics from the Centre for Genomics, Jiwaji University, Gwalior, India, in 2014. He is pursuing the Ph.D. degree in neuroscience with the Academy of Scientific and Innovative Research (AcSIR), Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India, on understanding the role of Gsk-3 in ne...View more
Author image of Pallavi Sharma
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Pallavi Sharma received the Ph.D. degree from the Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India, in 2022.
During her Ph.D., she has thoroughly investigated the role of central cAMP Response Element-Binding Protein (CREB)-Brain-Derived Neurotrophic Factor (BDNF) pathway in epilepsy and developed a flavonoid-ric...Show More
Pallavi Sharma received the Ph.D. degree from the Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India, in 2022.
During her Ph.D., she has thoroughly investigated the role of central cAMP Response Element-Binding Protein (CREB)-Brain-Derived Neurotrophic Factor (BDNF) pathway in epilepsy and developed a flavonoid-ric...View more
Author image of Vikram Patial
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Vikram Patial is a Principal Scientist with the Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, India. He is a veterinarian by profession with an expertise in veterinary pathology. His group focuses on the liver and kidney injury models to understand disease pathogenesis and explore the potential natural products and nutraceuticals for these conditions. He has ...Show More
Vikram Patial is a Principal Scientist with the Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, India. He is a veterinarian by profession with an expertise in veterinary pathology. His group focuses on the liver and kidney injury models to understand disease pathogenesis and explore the potential natural products and nutraceuticals for these conditions. He has ...View more
Author image of Damanpreet Singh
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Damanpreet Singh received the master’s degree from Guru Nanak Dev University, Amritsar, India, in 2008, and the Ph.D. degree in pharmacology from Punjabi University, Patiala, India, in 2013.
He joined the Department of Pharmaceutical Sciences and Drug Research, Punjabi University, as an Assistant Professor, and worked in the field of neuropharmacology. After that, he joined the Council of Scientific and Industrial Research...Show More
Damanpreet Singh received the master’s degree from Guru Nanak Dev University, Amritsar, India, in 2008, and the Ph.D. degree in pharmacology from Punjabi University, Patiala, India, in 2013.
He joined the Department of Pharmaceutical Sciences and Drug Research, Punjabi University, as an Assistant Professor, and worked in the field of neuropharmacology. After that, he joined the Council of Scientific and Industrial Research...View more
Author image of Shubhajit Roy Chowdhury
Biomedical Systems Laboratory, School of Computing and Electrical Engineering, Indian Institute of Technology Mandi, Kamand Campus, Mandi, Himachal Pradesh, India
Shubhajit Roy Chowdhury (Senior Member, IEEE) was born in 1981. He received the Ph.D. degree from the Department of Electronics and Telecommunication Engineering, Jadavpur University, Kolkata, India, in 2010.
He was an Assistant Professor with the Centre for Very large-scale Integration (VLSI) and Embedded Systems Technology, Indian Institute of Information and Technology (IIIT) Hyderabad, Hyderabad, India, and an Assistan...Show More
Shubhajit Roy Chowdhury (Senior Member, IEEE) was born in 1981. He received the Ph.D. degree from the Department of Electronics and Telecommunication Engineering, Jadavpur University, Kolkata, India, in 2010.
He was an Assistant Professor with the Centre for Very large-scale Integration (VLSI) and Embedded Systems Technology, Indian Institute of Information and Technology (IIIT) Hyderabad, Hyderabad, India, and an Assistan...View more

I. Introduction

Depressive disorders are one of the leading causes of disability [1], and chronic stress reported to be major contributors [2]. Excessive stress related events contribute toward depression-like behavior, which causes alteration in the brain structures, neurochemistry, and functions [3]. Depression-like behaviors cause imbalance of neuronal circuitry, which involves a change in the behavioral state [4]. Repetitive ignorance in the change in the behavioral state due to chronic stress leads to cognitive impairment, which can also involve losing the functional ability of memory and learning [4]. Furthermore, chronic stress-induced depression-like behavior imbalances the functionality of neurotransmitters. The previous studies reported deficits in serotonin or 5-hydroxytryptamine (5-HT) in stress and depression [5]. Furthermore, stress and depression were reported to disturb the function of -aminobutyric acid (GABA)-inhibitory and glutamate-excitatory neurotransmitters, which play a responsible role to control and exchange for neural circuit level information [6]. The previous brain imaging studies have observed functional and structural change in depression [7]. The microglial cells play an important role in controlling the glutamate level in the pathological conditions, which leads to neuronal survival or damage [8]. The key role of microglia-ramified cells is to provide surveillance to the neurons for external damage. Highly ramified microglia cells were seen in normal condition, but in the chronic stress condition, microglia cells lose their ramification and become amoeboid [3], [9]. Preclinical studies have observed some evidence related to decrease in the population of the neurons and number of microglia cells in stress and depression [9], [10]. Various researches are being carried out related to development of efficient precautionary and therapeutic procedures for mental disorders in various fields, such as physical medicine, pharmacology, biomedical and neural engineering, psychology and behavior, and many more [11], [12]. Several research works are being carried out to develop noninvasive, low cost portable, and easy to use neurorehabilitation, which can help to improve the lifestyle of patients and reduce the burden on caregivers [13].

Author image of Gaurav Sharma
Cognitive Brain Dynamics Laboratory, National Brain Research Centre (NBRC), Manesar, Haryana, India
Gaurav Sharma was born in Bharmout, Una, Himachal Pradesh, India, in August 1990. He received the M.Tech. degree in electronics and communication from Punjabi University, Patiala, India, in 2015, and the Ph.D. degree from the Indian Institute of Technology Mandi, Mandi, India, in 2021.
He is currently working as a Project Scientist-I and a Postdoctoral Fellow with the Cognitive Brain Dynamics Laboratory, National Brain Research Centre (NBRC), Manesar, Haryana, India, on a project to understand the brain connectivity and dynamics across the human lifespan. His primary areas of research involve noninvasive brain neuroimaging technology (MRI, electroencephalogram (EEG), and near infrared spectroscopy (NIRS)), noninvasive brain stimulation (NIBS), behavioral, and computational brain modeling. In addition, his primary research interest is to study science and technology together to facilitate personalized NIBS approaches to understand and treat severe common mental disorders.
Dr. Sharma received the Visvesvaraya Fellowship Scheme for the Ministry of Electronics and Information Technology (MeitY), Government of India, for his Ph.D. degree.
Gaurav Sharma was born in Bharmout, Una, Himachal Pradesh, India, in August 1990. He received the M.Tech. degree in electronics and communication from Punjabi University, Patiala, India, in 2015, and the Ph.D. degree from the Indian Institute of Technology Mandi, Mandi, India, in 2021.
He is currently working as a Project Scientist-I and a Postdoctoral Fellow with the Cognitive Brain Dynamics Laboratory, National Brain Research Centre (NBRC), Manesar, Haryana, India, on a project to understand the brain connectivity and dynamics across the human lifespan. His primary areas of research involve noninvasive brain neuroimaging technology (MRI, electroencephalogram (EEG), and near infrared spectroscopy (NIRS)), noninvasive brain stimulation (NIBS), behavioral, and computational brain modeling. In addition, his primary research interest is to study science and technology together to facilitate personalized NIBS approaches to understand and treat severe common mental disorders.
Dr. Sharma received the Visvesvaraya Fellowship Scheme for the Ministry of Electronics and Information Technology (MeitY), Government of India, for his Ph.D. degree.View more
Author image of Shubham Nilkanth Rahmatkar
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Shubham Nilkanth Rahmatkar received the master’s degree in pharmacology from the S.K.B. College of Pharmacy, Maharashtra, India, in 2018. He is pursuing the Ph.D. degree in pharmacology with the Academy of Scientific and Innovative Research (AcSIR), Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India.
In his master’s, he explored the role of hippocampal agmatine in β-amyloid induced memory impairment in mice. He is a Senior Research Fellow with the Pharmacology and Toxicology Laboratory, CSIR-IHBT. He is currently working on targeting the Gsk-3 pathway using natural products for neuroprotection.
Shubham Nilkanth Rahmatkar received the master’s degree in pharmacology from the S.K.B. College of Pharmacy, Maharashtra, India, in 2018. He is pursuing the Ph.D. degree in pharmacology with the Academy of Scientific and Innovative Research (AcSIR), Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India.
In his master’s, he explored the role of hippocampal agmatine in β-amyloid induced memory impairment in mice. He is a Senior Research Fellow with the Pharmacology and Toxicology Laboratory, CSIR-IHBT. He is currently working on targeting the Gsk-3 pathway using natural products for neuroprotection.View more
Author image of Anil Kumar Rana
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Anil Kumar Rana received the master’s degree in molecular and human genetics from the Centre for Genomics, Jiwaji University, Gwalior, India, in 2014. He is pursuing the Ph.D. degree in neuroscience with the Academy of Scientific and Innovative Research (AcSIR), Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India, on understanding the role of Gsk-3 in neurobehavior impairment following cerebral ischemia-reperfusion injury.
At Jiwaji University, he conducted research on the epigenetic alternation in the transgelin gene among patients with gall bladder cancer. His current research interests include developing a deeper understanding of the mechanisms involved in neuronal circuit rewiring after neurotrauma, with the goal of developing more effective treatments for individuals with neurological injuries.
Anil Kumar Rana received the master’s degree in molecular and human genetics from the Centre for Genomics, Jiwaji University, Gwalior, India, in 2014. He is pursuing the Ph.D. degree in neuroscience with the Academy of Scientific and Innovative Research (AcSIR), Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India, on understanding the role of Gsk-3 in neurobehavior impairment following cerebral ischemia-reperfusion injury.
At Jiwaji University, he conducted research on the epigenetic alternation in the transgelin gene among patients with gall bladder cancer. His current research interests include developing a deeper understanding of the mechanisms involved in neuronal circuit rewiring after neurotrauma, with the goal of developing more effective treatments for individuals with neurological injuries.View more
Author image of Pallavi Sharma
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Pallavi Sharma received the Ph.D. degree from the Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India, in 2022.
During her Ph.D., she has thoroughly investigated the role of central cAMP Response Element-Binding Protein (CREB)-Brain-Derived Neurotrophic Factor (BDNF) pathway in epilepsy and developed a flavonoid-rich nutraceutical formulation with enhanced bioavailability or the management of epileptic seizures and related comorbid conditions.
Dr. Sharma qualified the Graduate Pharmacy Aptitude Test and also received the Senior Research Fellowship from the Indian Council of Medical Research.
Pallavi Sharma received the Ph.D. degree from the Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India, in 2022.
During her Ph.D., she has thoroughly investigated the role of central cAMP Response Element-Binding Protein (CREB)-Brain-Derived Neurotrophic Factor (BDNF) pathway in epilepsy and developed a flavonoid-rich nutraceutical formulation with enhanced bioavailability or the management of epileptic seizures and related comorbid conditions.
Dr. Sharma qualified the Graduate Pharmacy Aptitude Test and also received the Senior Research Fellowship from the Indian Council of Medical Research.View more
Author image of Vikram Patial
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Vikram Patial is a Principal Scientist with the Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, India. He is a veterinarian by profession with an expertise in veterinary pathology. His group focuses on the liver and kidney injury models to understand disease pathogenesis and explore the potential natural products and nutraceuticals for these conditions. He has published over 50 peer-reviewed articles in reputed journals and five book chapters.
Vikram Patial is a Principal Scientist with the Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, India. He is a veterinarian by profession with an expertise in veterinary pathology. His group focuses on the liver and kidney injury models to understand disease pathogenesis and explore the potential natural products and nutraceuticals for these conditions. He has published over 50 peer-reviewed articles in reputed journals and five book chapters.View more
Author image of Damanpreet Singh
Pharmacology and Toxicology Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
Damanpreet Singh received the master’s degree from Guru Nanak Dev University, Amritsar, India, in 2008, and the Ph.D. degree in pharmacology from Punjabi University, Patiala, India, in 2013.
He joined the Department of Pharmaceutical Sciences and Drug Research, Punjabi University, as an Assistant Professor, and worked in the field of neuropharmacology. After that, he joined the Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, India, as a Scientist, and continued exploring the molecular basis of selected natural products in managing neurological disorders. He is working as a Principal Scientist with the Pharmacology and Toxicology Laboratory, CSIR-Institute of Himalayan Bioresource Technology. His research group is focused on identifying mammalian target of rapamycin (mTOR) and Gsk-3 pathway inhibitors to explore their therapeutic potential for managing chronic neurological conditions.
Damanpreet Singh received the master’s degree from Guru Nanak Dev University, Amritsar, India, in 2008, and the Ph.D. degree in pharmacology from Punjabi University, Patiala, India, in 2013.
He joined the Department of Pharmaceutical Sciences and Drug Research, Punjabi University, as an Assistant Professor, and worked in the field of neuropharmacology. After that, he joined the Council of Scientific and Industrial Research (CSIR)-Institute of Himalayan Bioresource Technology, Palampur, India, as a Scientist, and continued exploring the molecular basis of selected natural products in managing neurological disorders. He is working as a Principal Scientist with the Pharmacology and Toxicology Laboratory, CSIR-Institute of Himalayan Bioresource Technology. His research group is focused on identifying mammalian target of rapamycin (mTOR) and Gsk-3 pathway inhibitors to explore their therapeutic potential for managing chronic neurological conditions.View more
Author image of Shubhajit Roy Chowdhury
Biomedical Systems Laboratory, School of Computing and Electrical Engineering, Indian Institute of Technology Mandi, Kamand Campus, Mandi, Himachal Pradesh, India
Shubhajit Roy Chowdhury (Senior Member, IEEE) was born in 1981. He received the Ph.D. degree from the Department of Electronics and Telecommunication Engineering, Jadavpur University, Kolkata, India, in 2010.
He was an Assistant Professor with the Centre for Very large-scale Integration (VLSI) and Embedded Systems Technology, Indian Institute of Information and Technology (IIIT) Hyderabad, Hyderabad, India, and an Assistant Professor with the School of Computing and Electrical Engineering, Indian Institute of Technology (IIT) Mandi, Mandi, India. He was a Lecturer with Jadavpur University from 2006 to 2010. He is currently an Associate Professor with the School of Computing and Electrical Engineering, IIT Mandi. He has authored or coauthored over 150 articles in international journals and conferences. He has authored six books and book chapters. He has filed five patents and has been granted one U.S. patent and two Indian copyrights in the field of noninvasive medical diagnosis. His research interests span around the development of biomedical embedded systems, VLSI architectures, near infrared spectroscopy (NIRS)-based noninvasive diagnosis, and application-specific integrated circuits (ASIC) design of intelligent signal processing circuits. He is keenly interested in the educational system and its necessary transformation.
Dr. Roy Chowdhury is a member of the VLSI Society of India and the Association for Computing Machinery (ACM). He is a member of the scientific, technical, and editorial committee of the Engineering and Natural Sciences Division, World Academy of Engineering, Science and Technology. He is a Life Member of the Indian Statistical Institute, the Microelectronics Society of India, the Institution of Electronic and Telecommunication Engineers, and the Telemedicine Society of India. He received the University Gold Medals in 2004 and 2006 for the B.E. and M.E. degrees, respectively, the Altera Embedded Processor Designer Award in 2007, and the Winner of five Best Paper Awards, such as the Fellow of Society of Applied Biotechnology (FSAB) Award by the Society of Applied Biotechnology in 2012, the Young Engineers Award 2012–2013 by the Institution of Engineers, India, for his outstanding contribution in the field of electronics and telecommunication engineering, and the Fellow of the Association Award for the Advancement of Biodiversity Sciences in 2014.
Shubhajit Roy Chowdhury (Senior Member, IEEE) was born in 1981. He received the Ph.D. degree from the Department of Electronics and Telecommunication Engineering, Jadavpur University, Kolkata, India, in 2010.
He was an Assistant Professor with the Centre for Very large-scale Integration (VLSI) and Embedded Systems Technology, Indian Institute of Information and Technology (IIIT) Hyderabad, Hyderabad, India, and an Assistant Professor with the School of Computing and Electrical Engineering, Indian Institute of Technology (IIT) Mandi, Mandi, India. He was a Lecturer with Jadavpur University from 2006 to 2010. He is currently an Associate Professor with the School of Computing and Electrical Engineering, IIT Mandi. He has authored or coauthored over 150 articles in international journals and conferences. He has authored six books and book chapters. He has filed five patents and has been granted one U.S. patent and two Indian copyrights in the field of noninvasive medical diagnosis. His research interests span around the development of biomedical embedded systems, VLSI architectures, near infrared spectroscopy (NIRS)-based noninvasive diagnosis, and application-specific integrated circuits (ASIC) design of intelligent signal processing circuits. He is keenly interested in the educational system and its necessary transformation.
Dr. Roy Chowdhury is a member of the VLSI Society of India and the Association for Computing Machinery (ACM). He is a member of the scientific, technical, and editorial committee of the Engineering and Natural Sciences Division, World Academy of Engineering, Science and Technology. He is a Life Member of the Indian Statistical Institute, the Microelectronics Society of India, the Institution of Electronic and Telecommunication Engineers, and the Telemedicine Society of India. He received the University Gold Medals in 2004 and 2006 for the B.E. and M.E. degrees, respectively, the Altera Embedded Processor Designer Award in 2007, and the Winner of five Best Paper Awards, such as the Fellow of Society of Applied Biotechnology (FSAB) Award by the Society of Applied Biotechnology in 2012, the Young Engineers Award 2012–2013 by the Institution of Engineers, India, for his outstanding contribution in the field of electronics and telecommunication engineering, and the Fellow of the Association Award for the Advancement of Biodiversity Sciences in 2014.View more
Contact IEEE to Subscribe

References

References is not available for this document.